Patent Yard Sign in
Canadian application, no grantCanada

Piperidine derivatives

CA 2086413 A1 · Owner: Maruo, Shigeaki · Inventors: Miyazaki, Katsunori; Maruo, Shigeaki; Ezure, Yohji

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

A 3,4,5-trihydroxypiperidine derivative of general formula (I) having a .beta.-galactosidase inhibitory action and therefore usable as a carcinostatic agent, wherein R represents a C1 to C18 saturated or unsaturated hydrocarbon group which may be substituted with a linear, branched or cyclic group.

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed June 27, 1991. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended June 27, 2011.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by June 27, 2013.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledJune 27, 1991
GrantedNo grant recorded
Term endedJune 27, 2011
Patent numberCA 2086413 A1
Classification (IPC)C07D211/46 +2 more

Timeline

Timeline From CIPO dates

1992199419961998200020022004200620082010Application filedJune 27, 1991Term endedJune 27, 2011

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.